An electric vehicle battery, also known as traction battery is used to power the propulsion of electric vehicles. Electric vehicle battery is a secondary (rechargeable) battery. It uses chemical energy stored in rechargeable battery packs for power; and therefore does not require any combustion engine for propulsion. Recycling of the battery can recover metals such as aluminum, nickel, lithium, and other types of precious metals, which can be hazardous for the environment but can be recycled. It is assumed that EV battery offers a useful life in a vehicle until and unless they degrade to 80% of their original capacity.

Ongoing advancements in the fin fish market owing to innovative efforts have further enhanced the efficiency and productivity of the fin fish industry. The competitive advantages of fin fish over traditional fishing have been also described in the report. In addition, leading categories of finfish are studied in the report whereas the others segment includes mollusks, crustaceans, crabs, octopus, prawns and seals, dolphins and turtles, and comprise diverse group of aquatic animals that reside in oceans as well as in freshwater. The market, drivers, restraints, and opportunities of the market are explained in the report. Further, the key strategies adopted by potential market leaders to facilitate the effective planning are also discussed under the scope of the report.

The competitive landscape and structure of India’s transportation sector is different depending on the segment. What is common to all segments is that they are quite capital intensive and mature, which makes the entry of new players problematic. Companies tend to work at low margins, civil aviation companies and road passenger carriers in particular. This is because the government has enacted travel fare regulation policies to ensure that passenger travel is affordable to all Indians. The situation is particularly dire in the bus and railway segments. Bus carriers are usually debt-laden because of low fares, obligations to service unprofitable routes alongside the profitable ones and growing requirements for the environmental friendliness of vehicles, coupled with fuel price risks. The national railways, in turn, are grappling with non-paying passengers, technical obsolescence and the need to fulfil its widely recognised duties for social inclusion.

The Indian healthcare Industry has undergone significant transformation over the past three decades. From one dominated by public sector hospitals, it has shifted to being dominated by private hospitals in a response to the changing healthcare needs of the population. The private sector that dominates the secondary and tertiary healthcare segments, accounts for around 70% of total health care spending in India as of FY2018. Approximately 75% of all hospitals and 40% of total hospital beds - particularly in the secondary and tertiary healthcare segments - are owned and operated by the private sector. During FY2014-FY2018, India’s hospital sector grew at a CAGR of 8% to USD 87bn in FY2018. The key drivers of healthcare services in India are the increase in patient population and the resulting higher spending on healthcare services.

Aqueous sodium silicate, chemically known as water glass, is a colorless and clear liquid, which majorly finds application in waterproofing, detergents, soaps, and adhesives among others. The U.S. Liquid sodium silicate industry is anticipated to grow at a moderate rate due to its increasing demand in elastomer and catalyst applications. The product is largely used in oil & gas refineries as a catalyst for fluid catalytic cracking and hydrocracking process. Furthermore, the product finds application in paper & pulp industry, wherein it is commonly used as a bonding agent or an adhesive for bookbinding among other applications.

According to the International Classification of Diseases - 11 (2018), vision impairment is classified into four broad categories: mild vision impairment, moderate vision impairment, severe vision impairment, and blindness.

The report covers a study of the global protein supplement market and provides the detailed analysis of the market trends, future estimations, and a thorough study of the global market based on type, form, source, distribution channel, and region. By type, the market is segmented into casein, whey protein, egg protein, soy protein, and others. Based on form, the market is segmented into powder, RTD liquid and protein bars. On the basis of source, it is segmented into animal and plant. Based on distribution channel, the market is segmented into supermarkets/hypermarkets, online, chemist/drugstore, nutrition store, health food store, specialist sports store, and others. Based on region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, KSA, South Africa and Rest of LAMEA). The study highlights Porter’s five forces analysis to determine the factors affecting the market growth. These factors include raw material prices, intense competition, end users, manufacturers, and suppliers. To understand the market movement, drivers, restraints, and opportunities are explained in the report.

The revenues generated through the sale of proteomics instruments, reagents, and services are considered in the scope of the current report. However, revenues associated with related technologies such as transcriptomics and genomics are not considered in the report.

Pharmacogenomics falls in the branch of precision medicine and deals with the drug response in an individual based on his/her genetic profile. It hence allows doctors to devise a tailor-made prescription for patients suffering from life-threatening diseases such as cancer, neurological, and cardiovascular disorders. Furthermore, use of pharmacogenomics-based diagnostic tests facilitates improved drug response, reduced probability of drug failure, enhanced drug efficiency, and higher survival rate in case of cancer. Pharmacogenomics majorly includes the use of bioinformatics tools and several molecular biology techniques to determine the reason for an individual patient's illness at a molecular level. Furthermore, treatment is followed with the use of required dosage to address an individual patient's illness. This report takes into consideration the revenue generated by the sales of instruments, reagents, software, solutions, services, and therapeutics used to practice pharmacogenomics.

Orthobiologics are substances that orthopedic surgeons use to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in the body; and when used in higher concentrations, orthobiologic substances help speed up the healing process. Osteoarthritis (OA) of knee is a common global cause of disability. There is an increase in the number of non-operative treatment options. Orthobiologic therapy has emerged as a novel yet effective modality for early OA. The report covers profiles of key product manufacturers in the market. These include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc.